iRadimed Raises FY2025 Adj EPS Guidance from $1.76-$1.86 to $1.84-$1.88 vs $1.82 Est; Raises FY2025 Sales Guidance from $80.000M-$82.500M to $82.500M-$83.500M vs $81.091M Est
Benzinga Newsdesk 1 year ago
NewsGuidance
iRadimed (NASDAQ:IRMD) raises FY2025 Adj EPS guidance from $1.76-$1.86 to $1.84-$1.88 vs $1.82 analyst estimate. Raises FY2025 sales outlook from $80.000 million-$82.500 million to $82.500 million-$83.500 million vs
iRadimed (NASDAQ:IRMD) raises FY2025 Adj EPS guidance from $1.76-$1.86 to $1.84-$1.88 vs $1.82 analyst estimate. Raises FY2025 sales outlook from $80.000 million-$82.500 million to $82.500 million-$83.500 million vs $81.091 million estimate.